biguanides has been researched along with Arteriosclerosis, Coronary in 4 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Insulin treatment in patients with type 2 diabetes mellitus affects the expression of inflammatory cytokines and subsequently modifies the thrombotic mechanisms in patients with coronary atherosclerosis, independently from the duration of diabetes and the extend of coronary artery disease." | 2.73 | Effects of insulin dependence on inflammatory process, thrombotic mechanisms and endothelial function, in patients with type 2 diabetes mellitus and coronary atherosclerosis. ( Antoniades, C; Bosinakou, E; Latsios, G; Marinou, K; Papageorgiou, N; Siasos, G; Stefanadi, E; Stefanadis, C; Tentolouris, C; Tousoulis, D; Tsioufis, C, 2007) |
| "Individuals with type 2 diabetes (T2DM) are at increased risk of cardiovascular disease, including heart failure (HF)." | 1.39 | Metformin treatment may be associated with decreased levels of NT-proBNP in patients with type 2 diabetes. ( Czlonkowski, A; Filipiak, KJ; Kaplon-Cieslicka, A; Opolski, G; Postula, M; Rosiak, M; Trzepla, E, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rosiak, M | 1 |
| Postula, M | 1 |
| Kaplon-Cieslicka, A | 1 |
| Trzepla, E | 1 |
| Czlonkowski, A | 1 |
| Filipiak, KJ | 1 |
| Opolski, G | 1 |
| Kume, A | 1 |
| Miyazaki, T | 1 |
| Daida, H | 1 |
| Antoniades, C | 1 |
| Tousoulis, D | 1 |
| Marinou, K | 1 |
| Papageorgiou, N | 1 |
| Bosinakou, E | 1 |
| Tsioufis, C | 1 |
| Stefanadi, E | 1 |
| Latsios, G | 1 |
| Tentolouris, C | 1 |
| Siasos, G | 1 |
| Stefanadis, C | 1 |
| Korkushko, OV | 1 |
| Bogatskaia, LN | 1 |
| Kovalenko, AN | 1 |
| Novikova, SN | 1 |
| Kotko, DN | 1 |
1 review available for biguanides and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
[Treatment for coronary artery disease patients with impaired glucose tolerance].
Topics: Acarbose; Biguanides; Coronary Artery Bypass; Coronary Artery Disease; Glucose Intolerance; Glycosid | 2005 |
1 trial available for biguanides and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Effects of insulin dependence on inflammatory process, thrombotic mechanisms and endothelial function, in patients with type 2 diabetes mellitus and coronary atherosclerosis.
Topics: Aged; Biguanides; Blood Coagulation Factors; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dru | 2007 |
2 other studies available for biguanides and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Metformin treatment may be associated with decreased levels of NT-proBNP in patients with type 2 diabetes.
Topics: Adrenergic beta-Antagonists; Aged; Atherosclerosis; Biguanides; Cardiovascular Diseases; Coronary Ar | 2013 |
[Correction of dyslipoproteinemia in middle-aged and elderly patients with atherosclerosis using Essentiale in combination with adebit].
Topics: Aged; Aged, 80 and over; Biguanides; Buformin; Coronary Artery Disease; Drug Evaluation; Drug Therap | 1989 |